Black Buddha Cannabis Receives Warm Welcome During MJBizCon

Photo of BBC Founder Roz McCarthy and Product Packaging.

BBC Founder, Roz McCarthy & Product Line

Black Buddha Cannabis Logo

Get Enlightened

BBC Announcing January 2022 Availability

Coming January 2022

New Black Owned, Social Equity Brand Elevating Enlightenment

When I walk into a dispensary I get overwhelmed with all the product choices and options. I'm not there to get high, I just want to feel better.”

— Roz McCarthy

ORLANDO, FL, UNITED STATES, October 27, 2021 /EINPresswire.com/ — MJBizCon, the world's largest cannabis conference and exposition, was held last week, Oct 19-22nd. During the expo, industry stakeholders and participants were introduced to the newest black-owned, social-equity-driven brand: Black Buddha Cannabis (BBC). The brainchild behind BBC is Roz McCarthy, Founder/CEO of Minorities for Medical Marijuana (M4MM). Over the past five years, Roz has been leading the largest cannabis nonprofit advocacy organization. M4MM serves communities of color as it relates to social equity, social justice, health equity, and public policy.

Recently diagnosed with a traumatic brain injury after a terrible car collision, Roz integrated Cannabidiol (CBD), as well as Tetrahydrocannabinol (THC) flower into her recovery regimen. The debilitating effects of the concussion and whiplash prompted her caregiver and therapists to introduce Buddhist health and healing practices, like chanting and mantras, into her recovery health plan. Those positive outcomes gave birth to Black Buddha Cannabis.

Black Buddha Cannabis is a social-equity-driven brand created to make life easier for novice cannabis users who are experiencing and/or incorporating cannabis for the first time as a part of their wellness routine.

Learning about how marijuana affects your health regimen and interacts with your body can be a bit tricky. Roz recalled, "When I walk into a dispensary I get overwhelmed with all the product choices and options. I'm not there to get high, I just want to feel better." The different types of flowers (indica, sativa, or hybrid) and the individual strain effects, plus factors like the percentages of THC vs. CBD vs. the Terpene profile can all be overwhelming. Roz credited the reason that she created a brand of products like these is to make the purchasing experience less complicated.

BBC is a lifestyle brand that is all about becoming enlightened versus getting high. Consumers will have four different profile blends to choose from to meet their own personal or healthcare needs by choosing products based on how they feel versus how high they want to be. The profile blend choices are: Creativity, Enlightenment, Wellness, and Zen. The first product will be a pre-pack chillum, affectionately called a "One Hitter Quitter" (OHQ). The chillum is pre-packed with .05g of the profile blends of choice and will be sold as a pack of three. The OHQs provide a quick, easy, and discrete way to consume cannabis on the go. BBC's growing portfolio will include Mix-n-Sip's, teabags, and pain relief topical roll-on product options in the future. Currently, Roz and her team are in negotiations with five vertically integrated operators in Michigan, Massachusetts, Nevada, Ohio, and California, who are all excited about bringing her product to their respective marketplaces. If you want to learn more about BBC please go to www.blackbuddhacannabis.co. Products can be expected to be in stores by January 2022. A portion of sales revenue will support M4MM's Project Clean Slate expungement program.

Roz McCarthy
M4MM
+1 877-900-0832
email us here
Visit us on social media:
Facebook
LinkedIn
Other


Source: EIN Presswire

Advanced prostate cancer takes life of Friends’ actor, James Michael Tyler, at age 59

Gunther Friends show

Dr. David Samadi world renowned robotic surgeon, St Francis Hospital

Prostate cancer is a silent killer and not an old man disease.Screening can save your life. Go to prostatecancer911.com for questions about prostate cancer.

The second leading cause of cancer death in American men, prostate cancer, claimed the life of James Michael Tyler on Sunday, who played Gunther on the popular sitcom “Friends.” He died at 59.”

— Dr. David Samadi

NEW YORK, NEW YORK, UNITED STATES, October 27, 2021 /EINPresswire.com/ — The second leading cause of cancer death in American men, prostate cancer, claimed the life of James Michael Tyler on Sunday, who played Gunther on the popular sitcom “Friends.” He died at the age of 59.

“This is such a tragic loss for Tyler’s friends and family and for all of us who were fans of the show, Friends,” exclaimed Dr. David Samadi, Director of Men’s Health and Urologic Oncology at St. Francis Hospital in Roslyn, NY and author of The Ultimate MANual, Dr. Samadi’s Guide to Men’s Health and Wellness. “Prostate cancer is often referred to as an “old man’s disease,” yet up to 35 percent of men diagnosed with this disease, are in their forties or fifties.

Tyler was diagnosed with stage 4 prostate cancer in 2018 at the age of 56 after being screened for the disease at the time of his annual physical. The cancer had metastasized to his bones and he was undergoing chemotherapy treatment at the time of his death.

“It was the PSA test that found Tyler’s cancer,” explained Dr. Samadi. “This screening tool is commonly used for detecting prostate cancer and is known as a prostate specific antigen screening. I strongly advised all men get a baseline PSA screening at the age of 40 and then an annual PSA test each year. It’s true up to 65 percent diagnosed with prostate cancer are over age 65. Many of those men will die from something else besides prostate cancer. But we also know that prostate cancer can develop in younger men. And if a younger man is diagnosed with prostate cancer, it often is more aggressive and deadly.”

The PSA test is a simple test that measures the amount of prostate specific antigen present in the blood and is used to screen for prostate cancer. PSA is a protein that men have in their blood which is released by the prostate gland. In healthy men, the amount of PSA is low – generally less than 4.0 ng/ml. However, as men age, their prostate can experience physiological or pathological changes which cause the PSA to rise.

“Men should also be aware of other risk factors for prostate cancer,” stated Dr. Samadi. “For example, a family history of prostate cancer makes a difference. A man’s odds of a prostate cancer diagnosis double if he has a close relative such as a father or brother who had the disease. And this does not just apply to the men in your family. There’s also an increased risk for men who have a female first-degree relative (mother or sister) in their family who’s had breast cancer.”

Dr. Samadi wants all men to know that the earlier prostate cancer is diagnosed, the better chance of beating it back.

“Prostate cancer, no matter what a man’s age, can come as a complete shock,” said Dr. Samadi. “The good news for men is that early detection, improved treatments such as robotic assisted laparoscopic prostatectomy, and having new mediations have boosted prostate cancer’s survival rate to 90 percent. Nearly all men will survive it and likely die of another cause.”

Having annual PSA screenings and knowing your family history for both prostate and breast cancer, is an excellent start to outsmarting this disease, according to Dr. Samadi. He also adds eating a healthy diet, maintaining a healthy body weight, not smoking, and exercising regularly, as key lifestyle modifications men should adopt helping reduce their risk.

Dr. Samadi added his final thoughts, “One in eight American men will be told they have prostate cancer in their lifetime. Even though most of those men will be older at the time of diagnosis, young men are still at risk. James Michael Tyler’s death should be a reminder for younger men to talk to their doctor about PSA screening. It could very well end up saving their life.”

Dr. David Samadi is the Director of Men’s Health and Urologic Oncology at St. Francis Hospital in Long Island. He’s a renowned and highly successful board certified Urologic Oncologist Expert and Robotic Surgeon in New York City, regarded as one of the leading prostate surgeons in the U.S., with a vast expertise in prostate cancer treatment and Robotic-Assisted Laparoscopic Prostatectomy. Dr. Samadi is a medical contributor to NewsMax TV and is also the author of The Ultimate MANual, Dr. Samadi’s Guide to Men’s Health and Wellness, available online both on Amazon and Barnes & Noble. Visit Dr. Samadi’s websites at robotic oncolo gy and prostate cancer 911.

Dr. David Samadi
Robotic Oncology
+13475330444 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Dr David Samadi raising awareness for prostate cancer


Source: EIN Presswire

Ankylosing Spondylitis Drugs Market is Projected to Grow at a CAGR of 9.14% from 2021 to 2028

The global ankylosing spondylitis drugs market is estimated to reach USD 9.82 billion by 2028, at a CAGR of 9.14% from 2021 to 2028.

NEWARK, UNITED STATES, NEW JERSEY, October 27, 2021 /EINPresswire.com/ — As per the report published by The Brainy Insights, the global ankylosing spondylitis drugs market is expected to grow from USD 4.93 billion in 2020 to USD 9.82 billion by 2028, at a CAGR of 9.14% during the forecast period 2021-2028. The North America region emerged as the largest market for the ankylosing spondylitis drugs market with a 40.6% share of the market revenue in 2020. This is because North America is growing tremendously in terms of the healthcare industry. North America region has become the hub for the technological development and transformation of the industry. Asia Pacific region is anticipated to grow at the highest CAGR of 9.7% over the forecast period in the global ankylosing spondylitis drugs market. Growing health awareness among the consumers and rising healthcare expenditure in the region, driving the growth of the market.

Get Free Sample Report: https://www.thebrainyinsights.com/enquiry/sample-request/12527

Some of the major companies in the global ankylosing spondylitis drugs market are Johnson & Johnson, Abbvie, Hetero, Merck & Co., BoehringerIngelheim, UCB, Amgen, Janssen Biotech, Inc., ZydusCadila and Izana Bioscience among others. To enhance their market position in the global ankylosing spondylitis drugs market, the key players are now focusing on adopting the strategies such as product innovations, recent developments, mergers & acquisitions, joint venture, collaborations, and partnership. For instance, in January 2019, ZydusCadila announced the launch of its biosimilarAdalimumab, and to be marketed under the brand name Exemptia, to treat autoimmune disorders such as rheumatoid arthritis, juvenile idiopathic arthritis, and Ankylosing Spondylitis.

The molecule type segment is divided into small molecules, biologics, and biosimilars. The biologics is anticipated to grow at the highest CAGR of 9.9% over the forecast period. This is attributable to its more promising results in clinical development as compared to other molecules. It helps to reduce the back pain and stiffness by targeting specific proteins in the immune system that cause inflammation, including tumour necrosis factor (TNF) and interleukin 17 (IL17). The route of administration segment includes oral and parental. The oral segment accounted for the major market share of 64.8% in 2020. This is mainly due to, major drugs for these conditions are given by oral route of administration. The distribution channel segment includes hospitals, pharmacy, retail pharmacy, and online pharmacy. Online pharmacy segment is anticipated to grow at the highest CAGR of 10.2% over the forecast period. The rising preference of patient for the online pharmacy due to convenience boosting the market growth.

Increasing incidence of ankylosing spondylitis across the globe, further propelling the growth of ankylosing spondylitis drugs market. In addition to this, an increasing proportion of female patients with ankylosing spondylitis, further fueling the growth of the market. However, adverse side effects of various drugs on the body and limited awareness about ankylosing spondylitis, are some of the key factors hindering the growth of the market.

Click Here to Access Full Report Copy

Customization of the Report:
The customization of this report is available as per the client’s need. The report can be customized according to your requirements. We consistently update our research offerings to provide our clients with the latest trends in the market. For customization and to know more about this business report, please contact our sales team at sales@thebrainyinsights.com or +1-315-215-1633. Our sales executives will ensure that you can get a report that fulfills your requirements and suits your needs.

About Us
The Brainy Insights is a market research company, aimed at providing actionable insights through data analytics to companies to improve their business acumen. We have a robust forecasting and estimation model to meet the clients' objectives of high-quality output within a short span of time. We provide both customized (clients' specific) and syndicate reports. Our repository of syndicate reports is diverse across all the categories and sub-categories across domains. Our customized solutions are tailored to meet the clients' requirement whether they are looking to expand or planning to launch a new product in the global market.

Contact Us

Mark Stone
The Brainy Insights
+1 315-215-1633
email us here


Source: EIN Presswire

Ligation Devices Market New Business Opportunities is Expected to Reach $ 1.68 Billion by 2030

Ligation Device

Growth of the ligation devices market is attributed to technological advancement related to ligation devices and increase in surge in number surgical procedures

PORTLAND, OR, UNITED STATES, October 27, 2021 /EINPresswire.com/ — The global ligation devices market was valued at $946.2 million in 2020, and is projected to reach $1,680.5 million by 2030, registering a CAGR of 6.1% from 2021 to 2030. Ligation devices are the set of instruments and accessories that help in binding a blood vessel or other tube in the body with a piece of medical graded thread or wire. Furthermore, these devices can also be utilized to remove or cut a specific part of the irregular tissue growth in the body. Ligation devices are very complex in nature and are designed to help assist during surgical procedures. These devices can be used in the management of conditions such as gastrointestinal problems, hemorrhoid development, left atrial appendage, and ureteral obstruction due to cardinal ligaments.

The accessories such as band ligators can be used for the removal of hemorrhoids and hence is an important accessory for performing the surgeries. Ligation accessories can be used in laparoscopic and open surgical procedures. In addition, ligation devices help for banding esophageal varices. They can be used in controlling pregnancy by performing tubectomy.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/12824

Attributed to the COVID-19 pandemic, healthcare workers, equipment, and facilities have been moved to cope with the rising number of patients with COVID-19. The pandemic caused major impediments in pharmaceutical and medical supply chains globally. Furthermore, the risk of spread of COVID-19 had led the government to declare stipulated lockdowns and a halt in export and import of various medical devices intra-country. This is expected to hinder the growth of ligation devices market during the forecast period.

Governments of various developed and developing countries declared stipulated lockdown, which led to a downfall in the number of elective surgeries, and thus decreased the rates of surgeries involving ligation devices. The increase in awareness regarding the need to avoid hospital acquired infections and risk of exposure to COVID-19 during the pandemic is anticipated to hinder the number of surgical procedures, consequently decreasing the growth of the ligation devices market during the forecast period. Furthermore, banning of import and export is expected to hinder the growth of the ligation devices market in the commenced period.

Increase in prevalence of ovarian and cervical cancers, which requires ligation devices for management of the condition, is anticipated to propel the market to generate higher revenue shares. In addition, rise in incidence of urological diseases that requires ligation devices to help remove the extra tissue growth fuels the market growth. Upsurge in prevalence of diseases that requires surgical treatment, especially minimally invasive surgery (MIS) would help the ligation devices market to generate higher revenue in the next few years. Surge in awareness programs for family planning by various governments from both developed and developing countries, led to an increase in rates of tubectomy and hence is expected to help the ligation devices market generate higher revenue during the forecast period. However, greater price of ligation devices will hamper the growth of the market. In addition, upsurge in potential of ligation devices in emerging countries is expected to help the market generate greater opportunities in the next few years.

The global ligation devices market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is categorized into handheld instruments and accessories. By application, the market is classified into gastrointestinal & abdominal surgeries, gynecological surgeries, cardiovascular surgeries, urological surgeries, and others. By end user, it is divided into hospitals and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

On the basis of product, the handheld instruments segment is anticipated to gain the highest revenue during the forecast period, owing to the surge in number of surgical procedures, which require ligation handheld instruments for performing surgery in both developed and developing countries. In addition, increase in incidences of cancer and need for controlling pregnancy rates that require ligation accessories would propel the growth of the segment during the forecast period. In addition, growth in awareness regarding the need for early therapeutics for cancer is anticipated to propel the growth of the segment in the coming few years.

Based on application, the cardiovascular surgeries segment is anticipated to gain the fastest CAGR during the forecast period, owing to increase in incidences of cardiovascular diseases and adoption of sedentary lifestyle causing risks of heart-related conditions. In addition, advancement in cardiovascular robotic surgery would help to surge the demand for ligation devices, and thus propel the growth of the segment in the next few years. Increase in awareness programs regarding the need to endure prior treatment options for cardiovascular diseases had let to the growth in demand for the segment during the forecast period.

On the basis of end user, the hospitals segment is anticipated to gain the highest revenue during the forecast period, owing to the surge in number of outpatients and inpatients preferring hospitals and higher investment of hospitals for getting improved accessories for ligation and related surgical procedures. In addition, growth in number of surgical procedures in hospitals is expected to help generate higher revenue shares by the segment in the coming years.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/12824

North America is projected to account for a significant share of the global ligation devices market during the forecast period. The market in the region is anticipated to grow in the future, owing to surge in healthcare expenditure and rise in patient population in the region. In addition, Asia-Pacific is projected to witness the fastest CAGR and highest revenue share during the forecast period, owing to large patient population and surge in infrastructural development in the region.

The Major Key Players Are:

Ethicon (Johnson and Johnson), Teleflex Incorporated, Olympus Corporation, Applied Medical, ConMed Corporation, Cooper Surgical, Genicon, Inc., Grena Think Medical, B.Braun Melsungen AG, and Medtronic PLC.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Animal Therapeutics & Diagnostics Market Analysis, Industry Forecast, 2030

Abdominal Aortic Aneurysm Repair Devices Market Industry Forecast, 2030

Spine Bone Stimulators Market Analysis, Industry Forecast, 2030

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Esoteric Testing Market Size to Generate $ 66.21 Billion by 2030 | Growth & Key Business Strategies

Esoteric Testings

Surge in number of diagnostic testing are expected to notably contribute toward the growth of the global esoteric testing market during the forecast period.

PORTLAND, OR, UNITED STATES, October 27, 2021 /EINPresswire.com/ — The global esoteric testing market size was valued at $ 20.218 billion in 2020, and is estimated to reach $ 66.214 billion by 2030, growing at a CAGR of 12.5% from 2021 to 2030.

Esoteric testing is defined as the analysis of rare molecules or substances, which are not performed in a routine clinical lab. Esoteric testing is conducted when a doctor requires additional detailed information about patient health to complete a diagnosis and monitor a therapeutic regimen. It requires sophisticated instruments and materials to analyze the result of collecting samples. Esoteric tests are conducted mostly in the medical field such as oncology, toxicology, serology, molecular diagnostic, genetic, and endocrinology. It provides diagnosis of life-threatening diseases, helps in management of chronic diseases, and enhances the quality of life. It offers real opportunities to improve medical treatment and enhance efficiency.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/12387

The COVID-19 outbreak is anticipated to have a positive impact on growth of the global esoteric testing market. The COVID-19 pandemic has stressed the healthcare systems in the world but increased the need for diagnostic service center and surged the demand for ELISA and RT-PCR test to detect COVID-19. For instance, in October 2020, the VEO Diagnostic launched distribution right in the U.S. for Accel ELISA COVID-19 total test kit to detect the number of antibodies in human serum. Attributed to increasing number of COVID-19 cases, surge in demand for diagnostic testing is an integral part of delivering patient care and controlling the spread of the disease. For instance, in 2020, a total of 646 government laboratories and 247 private laboratories reported to Indian Council of Medical Research (ICMR) for COVID testing. Subsequently, this leads to increase in demand for esoteric testing.

The factors that drive the growth of the esoteric testing market include rise in prevalence of chronic and infectious disease such as hypertension, cancer, HIV, cardiovascular disease, and diabetes; increase in number of geriatric population; advancement in technology in healthcare sectors; and surge in demand for enzyme linked immunosorbent assay (ELISA) and real time polymerase chain reaction (RT-PCR).

According to World Health Organization, in 2021, approximately 2.26 million and 2.21 million people in the world were reported to be diagnosed with breast cancer and lung cancer, respectively. As per the same source, in 2021, approximately 36.3 million people live with HIV across the globe. Market players are focusing on the development of novel approaches for use of esoteric testing technology. Moreover, in 2020, Cipla Limited, an Indian multinational pharmaceutical company, launched ELIFast, which is an IgG ELISA test used for detection of COVID-19 antibody. Furthermore, in 2021, Thermo Fisher Scientific launched Invitrogen attune CytPix flow cytometer, which enables the user to better understand the morphology and quality of cells.

The increase in prevalence of genomic disease, rise in demand for monoclonal antibody, advancement in R&D activities in pharmaceutical and biotechnology industry, and surge in the number of diagnostic tests are anticipated to drive the growth of the esoteric testing market. In addition, adoption of early diagnosis of disease has led to the development of innovative technologies in the healthcare sector, thereby propelling the growth of the market.

Moreover, initiatives taken by governments for development of the diagnostic service center and increase in number of medical laboratories are the key factors that boost the growth of the market. Furthermore, technological advancement in esoteric DNA sequencing technology and surge in the number of funding for various research activities and diagnostic testing propel the growth of the market. In addition, rise in demand for advanced tools for esoteric testing in healthcare to enhance efficiency and surge in demand for personalized medicine fuel the market growth.

The esoteric testing market is segmented on the basis of type, technology, end user, and region. On the basis of type, the market is divided into infectious disease testing, oncology testing, endocrinology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and other testing. The infectious disease testing segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of infection disease, development in healthcare laboratory, and advancements in technology for molecular diagnostic.

On the basis of technology, the market is classified into enzyme linked immunosorbent assay, chemiluminesnce immunoassay, mass spectrometry, real time polymerase chain reaction, DNA sequencing, flow cytometry, and other technologies. The chemiluminescence immunoassay segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of chronic diseases such as autoimmune disease, diabetics, heart disease, and cancer; surge in awareness about early diagnostic of disease; and advancement in R&D for drug discovery and development activities. On the basis of end user, the market is classified into hospital-based laboratories and independent and reference laboratories. The independent and reference laboratories segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in number of laboratories, high testing volumes, and surge in digitalization of diagnostic laboratories.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/12387

North America accounted for a majority of the global esoteric testing market share in 2020 and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of chronic disease and increase in number of diagnostic tests and technological advancement for esoteric testing in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in prevalence of chronic disease, rise in government initiative for diagnostic service, surge in demand for ELISA and RT-PCR test, and increase in awareness among population for self-diagnostic testing.

The Major Key Players Are:

ARUP Laboratories, Baylor Esoteric and Molecular Laboratory, Foundation Medicine, Healius Limited, Laboratory Corporation, Mayo Foundation for Medical Education and Research, OPKO Health, Quest Diagnostics, Sonic Healthcare Limited, and Stanford Clinical Pathology.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Respiratory Care Devices Market Analysis, Industry Forecast, 2030

Intraoperative Neuromonitoring Market Analysis, Industry Forecast, 2030

European Electrosurgical Devices Market Analysis, Industry Forecast, 2030

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Health Benefits of Raw Honey by Dr. Cass Ingram With Warning

raw honey from been never fed sugar

Dr. Cass Ingram – The Wilderness Doctor

honey from bees fed sugar, pesticides and GMP

Health Benefits of Raw Honey – From bees never fed sugar

honeybee on flower

Honeybee on Flower

Dr. Cass Ingram’s new book, Health Benefits of Raw Honey, educates readers on its many therapeutic uses but cautions – never consume honey from bees fed sugar.

Genuine raw honey, free of pesticides, chemicals, fake sugars, and never heated, will be found to be a treatment and cure for diseases and syndromes never before documented.”

— Dr. Cass Ingram

LAKE FOREST, FL, UNITED STATES, October 27, 2021 /EINPresswire.com/ — Author Dr. Cass Ingram explains the myriad curative uses of honey in his new book, "Health Benefits of Raw Honey – From bees never fed sugar." An osteopathic physician and medicinal plant researcher, Dr. Ingram, instructs readers that only raw honey versus the heavily heated or pasteurized type offers healing properties. Further, he exposes the current ethical position of beekeepers who care for their hives by taking all the honey for commercial use and feeding the bees sugar. This method prevents the bees from eating the honey they produce and kills them while also harming humans who eat the honey produced this way.

The book describes the health benefits of raw honey in aiding the immune system, the gut, kidneys, liver, gallbladder, and skin. “There are nearly 40 conditions listed in the book that raw honey can help. In many respects, this raw, unprocessed natural medicine is superior to anything else known. There is no drug in existence that remotely comes close to its powers,” said Dr. Ingram.

A recent edition of "Scientific American" contains an article on the honeybee sugar-feeding issue. Dr. Ingram writes about this article detailing the practice of many beekeepers who take all the honey for their own commercial use. They then feed the honeybees sugar and corn syrup instead of letting them eat the honey they make. Researchers have shown the bees suffer a type of poisoning from this diet that involves the inability to turn on the genes involved with immunity. Therefore, they have a reduced ability to fight off infection as well as stress.

Further, their enzymes, so critical for the production of quality honey, are deficient. These enzymes are also needed to break down the pesticides and herbicides they incidentally pick up in the fields. Refined sugar of any type is a deadly poison to them, just as it is with humans.

The health benefits described in the book only come from unadulterated raw honey. “Honey from bees fed sugar tainted with additives is likely to make health conditions worse. Once the honey is cooked excessively, it may even act as an anti-immune substance, feeding the growth of yeasts and bacteria,” warns Dr. Ingram.

“Genuine raw honey, free of pesticides, chemicals, fake sugars, and never heated, will be found to be a treatment and cure for diseases and syndromes never before documented. Impossible conditions will succumb to its powers, even those held as incurable,” said Dr. Ingram.

To get a free copy of "Health Benefits of Raw Honey – From bees never fed sugar," order a hard copy, and to find genuinely raw honey, visit www. assingram.com or call 800-295-3737.

About Dr. Cass Ingram

Dr. Cass Ingram, founder of PurelyWild™, is a nutritional physician who received a B.S. in Biology and Chemistry from the University of Iowa (1979) and a D.O. from the University of Osteopathic Medicine and Health Sciences in Des Moines, IA (1984). Known as the Wilderness Doctor, he is one of North America’s leading experts on the health benefits and disease-fighting properties of wild medicinal herb, tree, and spice extracts. The author of more than 25 books on natural healing, including "Health Benefits of Raw Honey – From bees never fed sugar," has given answers and hope to millions through his lectures and interviews on radio and TV programs across America.

Chrystal Gorges
The PR Group
+1 727-977-8580 ext. 103
email us here


Source: EIN Presswire

Cosmetic Laser Market Size, Industry Share, Growth and Research Report 2021-2026

Cosmetic Laser Market

Cosmetic Laser Market

SHERIDAN, ALABAMA, UNITED STATES, October 27, 2021 /EINPresswire.com/ — According to the latest report by IMARC Group, titled “Cosmetic Laser Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global cosmetic laser market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 13% during 2021-2026.

A cosmetic laser is utilized for surgical procedures to remove hair, tattoos, scars, wrinkles, sunspots, birthmarks, stretch marks, etc. It treats various skin conditions, such as skin resurfacing, and aids in improving the appearance of scars, lines, wrinkles, acne, etc., with precisely focused light sources. Cosmetic lasers offer numerous advantages, including decreased postoperative discomfort, minimized risk of wound infection, reduced blood loss, etc. Presently, the newly introduced carbon dioxide (CO2) technology, which helps in deep collagen stimulation, superficial tightening, pigment reduction, etc., is also being extensively used worldwide.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/cosmetic-laser-market/requestsample

Global Cosmetic Laser Market Trends:

The rising beauty consciousness among individuals, coupled with the widespread influence of social media for beauty standards, is driving the cosmetic laser market. Moreover, the expanding aging population who are focusing on maintaining a youthful appearance is also propelling the product demand. Besides this, the emerging trend of cosmetic tourism and minimally invasive surgeries (MIS) is acting as another growth-inducing factor. Furthermore, the increasing occurrences of several skin conditions caused by excessive sun exposure and high pollution levels are also catalyzing the market growth. Additionally, the growing adoption of body contouring devices to tighten lax skin and remove undesired fat is expected to fuel the cosmetic laser market over the forecasted period.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/cosmetic-laser-market

Global Cosmetic Laser Market 2021-2026 Analysis and Segmentation:

Competitive Landscape with Key Player:

The competitive landscape of the industry has also been examined along with the profiles of the key players being

Aerolase Corporation
Candela Corporation (Syneron Medical Ltd.)
Cutera
Cynosure
El.En. S.p.A.
Lumenis Ltd.
Sciton Inc
Shanghai Fosun Pharmaceutical (Group) Co. Ltd.
SharpLight Technologies Inc
Solta Medical Inc. (Bausch Health Companies Inc.).

Breakup by Modality:

Pulsed Dye Laser (PDL)
YAG Laser
Carbon Dioxide Laser
Erbium
Intense Pulsed Light (IPL)
Radiofrequency
Infrared
Others

Breakup by Product:

Ablative
Non-Ablative

Breakup by Application:

Hair Removal
Skin Resurfacing
Vascular Lesions
Scar and Acne Removal
Body Contouring
Others

Breakup by End User:

Hospitals
Skin Care Clinics
Cosmetics Surgical Centres

Breakup by Region:

North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

Market Performance (2015-2020)
Market Outlook (2021-2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Other Report:

Gcc Cat Food Market: https://www.imarcgroup.com/gcc-pet-food-market
North America Adult Diaper Market: https://www.imarcgroup.com/north-america-adult-diaper-market
Gcc Dog Food Market: https://www.imarcgroup.com/gcc-pet-food-market
China Sacharin Market: https://www.imarcgroup.com/china-saccharin-market
West Africa Food Services Market: https://www.imarcgroup.com/west-africa-food-services-market
North America Cigarette Market: https://www.imarcgroup.com/north-america-cigarette-market
North America Cigarette Lighter Market: https://www.imarcgroup.com/north-america-cigarette-lighter-market
North America Tft Lcd Market: https://www.imarcgroup.com/north-america-tft-lcd-panel-market
North America Exercise Bike Market: https://www.imarcgroup.com/north-america-exercise-bike-market
Europe Hydrogen Peroxide Market: https://www.imarcgroup.com/europe-hydrogen-peroxide-market

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+1 631-791-1145
email us here


Source: EIN Presswire

Global Nebulizers Market Size, Share 2021, Growth Rate, Trends, Forecast Till 2026

Nebulizers Market

Nebulizers Market

SHERIDAN, ALABAMA, UNITED STATES, October 27, 2021 /EINPresswire.com/ — The latest report by IMARC Group, titled “Nebulizers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, finds that the global nebulizers market size reached a value of US$ 1.67 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026.

Nebulizers are medical devices used for the direct delivery of medication into the human respiratory system. These electric or battery-powered machines convert the liquid drug into an aerosol form of mist or fine spray by utilizing compressed air. The essential components of a nebulizer include an air compressor, compressor tubing, nebulizer cup and a facemask or mouthpiece for inhaling. Nebulizers are generally prescribed to people suffering from a chronic progressive condition of lung disorders such as chronic bronchitis, pneumonia, and asthma. Nowadays, several types of nebulizers are used in hospitals, clinics and homes as they are cost-effective, user-friendly and provide immediate relief and long-lasting effect.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally–our estimates about the latest market trends and forecast values after considering the impact of this pandemic. These observations will be integrated into the report.

Request Free Sample Report: https://www.imarcgroup.com/nebulizers-market/requestsample

Global Nebulizer Market Trends:

Based on the nebulizer market research, hectic and stressful lifestyles have stimulated the rate of tobacco consumption, particularly in developing countries. This trend, along with the growing geriatric population and rising air pollution levels, has led to the increasing prevalence of chronic respiratory diseases, such as asthma and cystic fibrosis, in turn, boosting the demand for nebulizers across the globe. Also, various healthcare organizations are taking initiatives to improve the awareness of and access to respiratory care devices such as nebulizers among patients.

Moreover, the leading pharmaceutical companies are introducing ultrasonic nebulizers with enhanced functionality, high efficiency, increased portability and drug exposure, and low drug delivery time for people who are unable to breathe deeply.

Buy full report with table of contents: https://www.imarcgroup.com/nebulizers-market

Global Nebulizer Market 2021-2026 Analysis and Segmentation:

Some of the major players operating in the industry include:

Briggs Medical Service Company
Ca-Mi SRL
Besco Medical
Flyp Nebulizers
DeVilbiss Healthcare International
Omron Corporation
Becton
Dickinson and Company
Koninklijke Philips N.V.
Feellife Health Inc.
Invacare Corporation
Pari Medical Ltd.
Philips Respironics, Inc.
Agilent Technologies, Inc.
Medline Industries, Inc.
Graham Field (GF) Health Products, Inc.

Market Breakup by Product Type:

Pneumatic Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers
Others

Market Breakup by Portability:

Portable Nebulizers
Standalone Nebulizers

Market Breakup by End-User:

Hospitals and Clinics
Long Term Healthcare Centers
Homecare Settings
Outpatient Settings

Market Breakup by Application:

COPD
Cystic Fibrosis
Asthma
Others

Market Breakup by Region:

North America
Europe
Asia Pacific
Middle East and Africa
Latin America.

Key Highlights of the Report:

Market Performance (2015-2020)
Market Outlook (2021- 2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Other Report:

Australia Coffee And Tea Capsules Market: https://www.imarcgroup.com/australia-coffee-tea-capsules-market
France Silica Sand Market: https://www.imarcgroup.com/france-silica-sand-market
India Metal Casting Market: https://www.imarcgroup.com/india-metal-casting-market
India Microinsurance Market: https://www.imarcgroup.com/india-microinsurance-market
Asia Pacific Microinsurance Market: https://www.imarcgroup.com/asia-pacific-microinsurance-market
Europe Hot Sauce Market: https://www.imarcgroup.com/europe-hot-sauce-market
Baby Food And Infant Formula Ingredients Market: https://www.imarcgroup.com/baby-food-infant-formula-ingredients-market
Africa Microinsurance Market: https://www.imarcgroup.com/africa-microinsurance-market
India Automotive Glass Market: https://www.imarcgroup.com/india-automotive-glass-market
Japan Oral Hygiene Market: https://www.imarcgroup.com/japan-oral-hygiene-market

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+ +1 6317911145
email us here


Source: EIN Presswire

Medical Implant Market High trend Opportunities offers Future Business Growth by 2027

Increase in prevalence of chronic diseases, supportive initiatives from medical health insurance companies for critical issues

PORTLAND, OREGON, UNITED STATES, October 27, 2021 /EINPresswire.com/ — According to the report by Allied Market Research, titled, "Medical Implant Market By Product Type (Orthopedic Implants, Cardiovascular Implants, Spinal Implant, Neurostimulators, Ophthalmic Implants, Dental Implants, Facial Implants, and Breast Implants) and Biomaterial Type (Metallic Biomaterials, Ceramic Biomaterials, Polymers Biomaterials, and Natural Biomaterials): Global Opportunity Analysis and Industry Forecast, 2020–2027". The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Increase in prevalence of chronic diseases, supportive initiatives from medical health insurance companies for critical issues, and surge in awareness regarding different types of implants augment the growth of the global medical implant market. On the other hand, high cost of treatment and stringent approval process impede the market growth. Moreover, technological advancements in implants anticipates to create an array of opportunities for the market players.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/71

The medical implant industry estimated $85.38 billion in 2019, and is estimated to generate $147.46 billion by 2027, manifesting a CAGR of 7.2% from 2020 to 2027.

Covid-19 Scenario:

The covid-19 outbreak impacted the medical implant market negatively. The American College of Surgeons (ACS) has recently issued guidelines for triage of vascular surgery patients, suggesting to postpone non-emergency vascular procedures.

According to new government directives and hospital guidelines, vascular procedures have been restricted for life or limb salvaging cases only. The staff have been reallocated to Covid wards.

Comprehensive competitive analysis and profiles of major market players, such as

NuVasive, Inc.
Integra LifeSciences
Holding Corporation
Institut Straumann AG
Conmed Corporation
Medtronic Plc.
Johnson and Johnson
Boston Scientific Corporation
Biotronik , Globus Medical, Inc.
LivaNova PLC .

Key Benefits For Stakeholders:

• The study provides an in-depth analysis of the Medical Implant Market along with the current trends and future estimations to elucidate the imminent investment pockets.

• It offers Medical Implant Market analysis from 2020 to 2028, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.

• A comprehensive analysis of four regions is provided to determine the prevailing opportunities.

• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Medical Implant Market growth.

FREQUENTLY ASKED QUESTIONS?

Q1. What is the market value of Medical Implant Market report in forecast period?
Q2. What would be forecast period in the market report?
Q3. What is the market value of Medical Implant Market in 2020?
Q4. Which is base year calculated in the Medical Implant Market report?
Q5. Does the Medical Implant Market company is profiled in the report?
Q6. Which are the top companies hold the market share in Medical Implant Market?
Q7. Does the Medical Implant Market report provides Value Chain Analysis?
Q8. What are the key trends in the Medical Implant Market report?

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/71

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Defibrillators Market – Global Opportunity Analysis and Industry Forecast, 2020–2028

Cancer Biomarkers Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Specialty Enzymes Market to witness excellent revenue growth, emerging trends and forecast by 2028

Specialty enzymes have gained popularity in the recent years owing to their potential in various industries such as pharmaceutical, biotechnology research

PORTLAND, OREGON, UNITED STATES, October 27, 2021 /EINPresswire.com/ — According to the report by Allied Market Research, titled, "Specialty Enzymes Market by Types (Acylases, Hydratases, Humulin, Oxidase, Lyases, Restriction enzymes, Ligases, Polymerases, Lipases, Amylases, Proteases, Dehydrogenases, Glucouronidse) and By Source (Microorganisms, Plants, Animals) – Global Opportunity Analysis and Industry Forecast, 2021 – 2028". The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

The global specialty enzymes for pharmaceuticals, biotechnology R&D and diagnostics market is segmented based on the application, source, type and geography. Based on the applications, the market is segmented into pharmaceuticals, biotechnology R&D and diagnostics. Based on the source, the market is segmented into three types, namely microorganisms, plants and animals.

For Right Perspective and Competitive Insights, Get Sample Report at:

https://www.alliedmarketresearch.com/request-sample/703

Comprehensive competitive analysis and profiles of major market players, such as

Novozymes
DuPont
F. Hoffmann-La Roche AG
BASF
Life technologies
Advance enzyme Technologies Ltd
Affymetrix, Inc.
Codexis, Inc.

Key Benefits For Stakeholders:

• The study provides an in-depth analysis of the Specialty Enzymes Market along with the current trends and future estimations to elucidate the imminent investment pockets.

• It offers Specialty Enzymes Market analysis from 2020 to 2028, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.

• A comprehensive analysis of four regions is provided to determine the prevailing opportunities.

• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global Specialty Enzymes Market growth.

Purchase Enquiry:

https://www.alliedmarketresearch.com/purchase-enquiry/703

Table of Content:

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities…

FREQUENTLY ASKED QUESTIONS?

Q1. What is the market value of Specialty Enzymes Market report in forecast period?
Q2. What would be forecast period in the market report?
Q3. What is the market value of Specialty Enzymes Market in 2020?
Q4. Which is base year calculated in the Specialty Enzymes Market report?
Q5. Does the Specialty Enzymes Market company is profiled in the report?
Q6. Which are the top companies hold the market share in Specialty Enzymes Market?
Q7. Does the Specialty Enzymes Market report provides Value Chain Analysis?
Q8. What are the key trends in the Specialty Enzymes Market report?

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Small Animal Imaging Market – Global Opportunity Analysis and Industry Forecast, 2020–2028

Micromanipulators Market – Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+18007925285 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire